Comparison of efficacy of 8Spheres embolization microspheres and gelatin sponge particles in TACE

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900028658

Enrollment

Unknown

Registered

2019-12-29

Start date

2020-01-01

Completion date

Unknown

Last updated

2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HCC

Interventions

group A:embolism with gelatin sponge

group B:embolism with 8Spheres embolization microspheres

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1, Aged 18 - 80 years. 2, diagnosed as primary liver cancer. 3, liver function grade Child A, B. 4, ECOG score 0 -1.

Exclusion criteria

Exclusion criteria: 1. People with severe cardiovascular and cerebrovascular diseases. 2. with severe coagulation dysfunction. 3. patients with portal vein cancer embolus.

Design outcomes

Primary

Measure	Time frame
progression-free survival ;Disease response;	—

Secondary

Measure	Time frame
untoward effect;untoward effect;	—

Countries

China

Contacts

Public ContactHe Dongfeng

Department of Interventional, Harbin Medical University Cancer Hospital

13644578588@139.com+86 13644578588

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026